Medchem Organics Profile
Key Indicators
- Authorised Capital ₹ 10.01 Cr
as on 21-12-2024
- Paid Up Capital ₹ 10.00 Cr
as on 21-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 21-12-2024
- Satisfied Charges ₹ 23.50 Cr
as on 21-12-2024
- Revenue %
(FY 2021)
- Profit -3.01%
(FY 2021)
- Ebitda -2.50%
(FY 2021)
- Net Worth 1.02%
(FY 2021)
- Total Assets 0.35%
(FY 2021)
About Medchem Organics
The Corporate was formerly known as Svakrm Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.01 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹2.00 M. The company has closed loans amounting to ₹23.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mohan Adabala and Venkateswara Ganesula serve as directors at the Company.
- CIN/LLPIN
U24110TG2007PTC053487
- Company No.
053487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medchem Organics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Adabala  | Managing Director | 09-Apr-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkateswara Ganesula | Director | 09-Apr-2007 | Current |
Financial Performance of Medchem Organics.
Medchem Organics Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.01% decrease in profit. The company's net worth moved up by a moderate rise of 1.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medchem Organics?
In 2020, Medchem Organics had a promoter holding of 52.19% and a public holding of 47.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Emkay Finind Services India Private LimitedActive 10 years 10 monthsMohan Adabala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Jun 2016 | ₹2.00 M | Open |
Small Industries Development Bank Of India Creation Date: 23 Jan 2015 | ₹3.50 Cr | Satisfied |
State Bank Of Hyderabad Creation Date: 19 Jun 2014 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Medchem Organics?
Unlock and access historical data on people associated with Medchem Organics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medchem Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medchem Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
